Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
IMAX Quote, Financials, Valuation and Earnings
Last price:
$28.62
Seasonality move
:
-4.92%
Day range:
$27.89 - $28.86
52-week range:
$16.87 - $29.66
Dividend yield:
0%
P/E ratio:
60.17x
P/S ratio:
4.27x
P/B ratio:
5.07x
Volume:
1M
Avg. volume:
905.2K
1-year change:
63.47%
Market cap:
$1.5B
Revenue:
$352.2M
EPS (TTM):
$0.47
Analysts' Opinion
-
Consensus RatingImax has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $30.82, Imax has an estimated upside of 8.98% from its current price of $28.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $17.00 representing 39.89% downside risk from its current price of $28.28.
Fair Value
-
According to the consensus of 10 analysts, Imax has 8.98% upside to fair value with a price target of $30.82 per share.
IMAX vs. S&P 500
-
Over the past 5 trading days, Imax has overperformed the S&P 500 by 7.46% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Imax does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Imax has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Imax reported revenues of $86.7M.
Earnings Growth
-
Imax earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Imax reported earnings per share of $0.04.
Enterprise value:
1.8B
EV / Invested capital:
--
Price / LTM sales:
4.27x
EV / EBIT:
35.39x
EV / Revenue:
4.97x
PEG ratio (5yr expected):
7.54x
EV / Free cash flow:
44.62x
Price / Operating cash flow:
38.31x
Enterprise value / EBITDA:
15.44x
Gross Profit (TTM):
$196.5M
Return On Assets:
3.01%
Net Income Margin (TTM):
6.98%
Return On Equity:
6.95%
Return On Invested Capital:
3.91%
Operating Margin:
19.15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $327.7M | $367M | $359.8M | $79.1M | $86.7M | |
| Gross Profit | $174.6M | $211.2M | $196.5M | $46.9M | $53.2M | |
| Operating Income | $20.4M | $52.8M | $52.3M | $12.1M | $16.8M | |
| EBITDA | $72.8M | $115.6M | $115.7M | $27.7M | $32.1M | |
| Diluted EPS | -$0.12 | $0.48 | $0.47 | $0.06 | $0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $561.2M | $489.3M | $453M | $460.6M | $468.2M | |
| Total Assets | $942.4M | $852M | $821.5M | $824.1M | $848.3M | |
| Current Liabilities | $213.9M | $196.3M | $244.1M | $248.8M | $221.4M | |
| Total Liabilities | $506.9M | $438M | $487.7M | $490.8M | $464M | |
| Total Equity | $435.5M | $414.1M | $333.8M | $333.4M | $384.3M | |
| Total Debt | $273.3M | $225.1M | $258.6M | $297.5M | $279.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $42.3M | $26.4M | $88.8M | -$11M | $7M | |
| Cash From Investing | -$47M | -$34.6M | -$48.7M | -$7.1M | -$14.6M | |
| Cash From Financing | -$60.5M | -$10.7M | -$24.6M | $22.8M | $4.2M | |
| Free Cash Flow | $11.3M | -$9.3M | $40.1M | -$18.1M | -$7.7M | |
IMAX
Sector
Market Cap
$1.5B
$85.7M
Price % of 52-Week High
95.35%
71.43%
Dividend Yield
0%
0%
Shareholder Yield
-0.38%
3.73%
1-Year Price Total Return
63.47%
-9.01%
Beta (5-Year)
0.805
0.572
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$27.12
200-day SMA
Buy
Level
$24.79
Bollinger Bands (100)
Buy
Level
24.15 - 27.87
Chaikin Money Flow
Buy
Level
889.7K
20-day SMA
Buy
Level
$27.55
Relative Strength Index (RSI14)
Buy
Level
58.20
ADX Line
Buy
Level
27.87
Williams %R
Sell
Level
-19.398
50-day SMA
Buy
Level
$27.28
MACD (12, 26)
Buy
Level
7.53
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
831.4K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2984)
Sell
CA Score
(Annual)
Level (-0.744)
Buy
Beneish M-Score
(Annual)
Level (-2.8227)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (0.1098)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Stock Forecast FAQ
In the current month, IMAX has received 8 Buy ratings 1 Hold ratings, and 1 Sell ratings. The IMAX average analyst price target in the past 3 months is $30.82.
-
Where Will Imax Stock Be In 1 Year?
According to analysts, the consensus estimate is that Imax share price will rise to $30.82 per share over the next 12 months.
-
What Do Analysts Say About Imax?
Analysts are divided on their view about Imax share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Imax is a Sell and believe this share price will drop from its current level to $17.00.
-
What Is Imax's Price Target?
The price target for Imax over the next 1-year time period is forecast to be $30.82 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is IMAX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Imax is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IMAX?
You can purchase shares of Imax via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Imax shares.
-
What Is The Imax Share Price Today?
Imax was last trading at $28.62 per share. This represents the most recent stock quote for Imax. Yesterday, Imax closed at $28.28 per share.
-
How To Buy Imax Stock Online?
In order to purchase Imax stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
